دورية أكاديمية
Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens
| العنوان: | Subcutaneous Immunoglobulin 16.5% (Cutaquig®) in Primary Immunodeficiency Disease: Safety, Tolerability, Efficacy, and Patient Experience with Enhanced Infusion Regimens |
|---|---|
| المؤلفون: | Gupta, SudhirAff1, IDs10875023015094_cor1, DeAngelo, James, Melamed, Isaac, Walter, Jolan E., Kobayashi, Ai-Lan, Bridges, Tracy, Sublett, J. Wesley, Bernstein, Jonathan A., Koterba, Alan, Manning, Michael, Maltese, Joanna, Hoeller, Sonja, Turpel-Kantor, Eva, Kreuwel, Huub, Kobayashi, Roger H. |
| المصدر: | Journal of Clinical Immunology: International Journal of Inborn Errors of Immunity and Related Diseases. 43(6):1414-1425 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 02719142 15732592 |
|---|---|
| DOI: | 10.1007/s10875-023-01509-4 |